United States Biotechnology & Medical Research

Array BioPharma Inc (ARRY)

Track

Ticker: ARRY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sandor Victor
Chief Medical Officer
1 sale — total 2,851,000 USD
Planned sale 4 Jun 2019
Value US$3,066,714.09 | Price 324.03 | Shares 12,622
Planned sale 3 Jun 2019
Value US$1,037,954.33 | Price 422.15 | Shares 63,705
Planned sale 30 May 2019
Value US$432,520.00 | Price 27.50 | Shares 15,728
Planned sale 28 May 2019
Value US$2,022,929.74 | Price 27.00 | Shares 74,915
Planned sale 23 May 2019
Value US$1,076,845.70 | Price 26.50 | Shares 40,634
Planned sale 21 May 2019
Value US$333,900.00 | Price 26.50 | Shares 12,600
Buy 19 Feb 2019
Value US$115,998.00 | Price 23.20 | Shares 5,000
Planned sale 7 Feb 2019
Value US$1,874,301.00 | Price 22.05 | Shares 85,000
Planned sale 7 Feb 2019
Value US$2,380,015.00 | Price 21.64 | Shares 110,000
Planned sale 7 Feb 2019
Value US$4,041,756.36 | Price 21.58 | Shares 187,264
Planned sale 6 Feb 2019
Value US$234,240.00 | Price 20.00 | Shares 11,712
Sale 6 Feb 2019
Value US$104,261.00 | Price 20.85 | Shares 5,000
Sale 6 Feb 2019
Value US$104,120.50 | Price 20.82 | Shares 5,000
Sale 6 Feb 2019
Value US$512,692.50 | Price 20.51 | Shares 25,000
Sale 6 Feb 2019
Value US$4,798,510.65 | Price 20.03 | Shares 239,626
Planned sale 5 Feb 2019
Value US$800,000.00 | Price 20.00 | Shares 40,000
Planned sale 31 Jan 2019
Value US$2,101,541.04 | Price 18.53 | Shares 113,438
Planned sale 30 Jan 2019
Value US$1,825,370.00 | Price 18.25 | Shares 100,000
Planned sale 25 Jan 2019
Value US$252,523.40 | Price 18.00 | Shares 14,029
Planned sale 18 Jan 2019
Value US$22,518.00 | Price 18.00 | Shares 1,251
Planned sale 15 Jan 2019
Value US$356,139.26 | Price 18.06 | Shares 19,720
Planned sale 27 Dec 2018
Value US$88,091.10 | Price 14.05 | Shares 6,268
Planned sale 3 Dec 2018
Value US$1,867,045.18 | Price 16.21 | Shares 115,185
Buy 1 Nov 2018
Value US$50,595.30 | Price 16.87 | Shares 3,000
Planned sale 19 Sep 2018
Value US$265,683.60 | Price 14.76 | Shares 18,000
Planned sale 4 Sep 2018
Value US$148,937.62 | Price 15.38 | Shares 9,687
Planned sale 15 Aug 2018
Value US$278,400.00 | Price 13.92 | Shares 20,000
Planned sale 15 Aug 2018
Value US$299,280.00 | Price 13.92 | Shares 21,500
Planned sale 30 Jul 2018
Value US$371,750.00 | Price 14.87 | Shares 25,000
Planned sale 18 Jul 2018
Value US$356,040.00 | Price 16.56 | Shares 21,500
Sale 6 Jul 2018
Value US$872,500.00 | Price 17.45 | Shares 50,000
Planned sale 27 Jun 2018
Value US$318,681.36 | Price 17.74 | Shares 17,964
Planned sale 27 Jun 2018
Value US$2,535,468.75 | Price 18.03 | Shares 140,625
Planned sale 27 Jun 2018
Value US$773,960.72 | Price 17.74 | Shares 43,628
Planned sale 20 Jun 2018
Value US$410,220.00 | Price 19.08 | Shares 21,500
Planned sale 19 Jun 2018
Value US$1,455,325.76 | Price 18.76 | Shares 77,576
Planned sale 13 Jun 2018
Value US$420,450.00 | Price 18.75 | Shares 22,424
Planned sale 16 May 2018
Value US$330,259.35 | Price 15.36 | Shares 21,500
Planned sale 18 Apr 2018
Value US$326,585.00 | Price 15.19 | Shares 21,500
Planned sale 3 Apr 2018
Value US$133,376.15 | Price 15.35 | Shares 8,689
Planned sale 21 Mar 2018
Value US$360,340.00 | Price 16.76 | Shares 21,500
Planned sale 9 Mar 2018
Value US$1,976,098.96 | Price 17.72 | Shares 111,518
Planned sale 9 Mar 2018
Value US$787,614.60 | Price 17.70 | Shares 44,498
Planned sale 21 Feb 2018
Value US$368,940.00 | Price 17.16 | Shares 21,500
Sale 9 Feb 2018
Value US$845,000.00 | Price 16.90 | Shares 50,000
Sale 9 Feb 2018
Value US$850,500.00 | Price 17.01 | Shares 50,000
Planned sale 17 Jan 2018
Value US$278,210.00 | Price 12.94 | Shares 21,500
Planned sale 16 Jan 2018
Value US$102,975.00 | Price 13.73 | Shares 7,500
Planned sale 19 Dec 2017
Value US$5,970,326.69 | Price 10.93 | Shares 546,233
Planned sale 18 Dec 2017
Value US$2,933,989.74 | Price 10.73 | Shares 273,438
Planned sale 18 Dec 2017
Value US$3,032,409.28 | Price 10.72 | Shares 282,874
Sale 29 Sep 2017
Value US$478,428.15 | Price 12.31 | Shares 38,865
Sale 29 Sep 2017
Value US$493,510.08 | Price 12.36 | Shares 39,928
Sale 31 Mar 2017
Value US$401,400.00 | Price 8.92 | Shares 45,000
Sale 28 Mar 2017
Value US$231,750.00 | Price 9.27 | Shares 25,000
Sale 28 Sep 2016
Value US$15,852,796.08 | Price 6.36 | Shares 2,492,578
Buy 15 Sep 2016
Value US$98,000.00 | Price 3.50 | Shares 28,000
Sale 15 Sep 2016
Value US$25,842.00 | Price 3.54 | Shares 7,300
Buy 14 Sep 2016
Value US$1,305,720.00 | Price 3.51 | Shares 372,000
Sale 14 Sep 2016
Value US$1,374,450.00 | Price 3.50 | Shares 392,700
Buy 20 Jan 2016
Value US$957,000.00 | Price 3.19 | Shares 300,000
Buy 12 Jan 2016
Value US$270,000.00 | Price 3.60 | Shares 75,000
Buy 11 Jan 2016
Value US$973,500.00 | Price 3.54 | Shares 275,000
Buy 8 Jan 2016
Value US$1,302,000.00 | Price 3.72 | Shares 350,000
Buy 7 Jan 2016
Value US$1,119,000.00 | Price 3.73 | Shares 300,000
Buy 1 Oct 2015
Value US$450,630.00 | Price 4.50 | Shares 100,140
Buy 30 Sep 2015
Value US$852,050.84 | Price 4.67 | Shares 182,452
Buy 29 Sep 2015
Value US$2,280,000.00 | Price 4.56 | Shares 500,000
Buy 26 Aug 2015
Value US$273,452.00 | Price 5.48 | Shares 49,900
Buy 25 Aug 2015
Value US$1,199,000.00 | Price 5.45 | Shares 220,000
Buy 24 Aug 2015
Value US$2,181,200.00 | Price 5.32 | Shares 410,000
Buy 21 Aug 2015
Value US$872,000.00 | Price 5.45 | Shares 160,000
Buy 12 Aug 2015
Value US$1,215,650.00 | Price 5.93 | Shares 205,000
Buy 11 Aug 2015
Value US$1,915,875.00 | Price 5.85 | Shares 327,500
Buy 10 Aug 2015
Value US$1,045,800.00 | Price 5.81 | Shares 180,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-06-06 2019-06-04 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
12,622 -42.9%
324.03
US$3,066,714 		12,622 -42.9% 324.03 US$3,066,714
2019-06-03 2019-06-03 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
63,705 +35.9%
422.15
US$1,037,954 		63,705 +35.9% 422.15 US$1,037,954
2019-06-03 2019-05-30 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
98,693 +30.3%
161.00
US$447,291 		98,693 +30.3% 161.00 US$447,291
2019-05-28 2019-05-28 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
74,915 -26.3%
27.00
US$2,022,930 		74,915 -26.3% 27.00 US$2,022,930
2019-05-28 2019-05-23 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
40,634 -14.6%
26.50
US$1,076,846 		40,634 -14.6% 26.50 US$1,076,846
2019-05-23 2019-05-21 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
12,600 -5.0%
26.50
US$333,900 		12,600 -5.0% 26.50 US$333,900
2019-02-21 2019-02-19 B Purchase
2.7
COX CARRIE SMITH
5,000 +166.7%
23.20
US$115,998 		5,000 +166.7% 23.20 US$115,998
2019-02-08 2019-02-07 PlS Planned sale
Haddock Jason

CFO
85,000 -73.9%
22.05
US$1,874,301 		85,000 -73.9% 22.05 US$1,874,301
2019-02-08 2019-02-07 PlS Planned sale
0.8
Squarer Ron

CEO
110,000 -31.5%
21.64
US$2,380,015 		110,000 -31.5% 21.64 US$2,380,015
2019-02-08 2019-02-07 PlS Planned sale
3.6
Saccomano Nicholas A

CSO
187,264 -56.8%
21.58
US$4,041,756 		187,264 -56.8% 21.58 US$4,041,756
2019-02-08 2019-02-06 PlS Planned sale
Haddock Jason

CFO
11,712 -28.0%
20.00
US$234,240 		11,712 -28.0% 20.00 US$234,240
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
5,000 -20.0%
20.85
US$104,261 		5,000 -20.0% 20.85 US$104,261
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
5,000 -16.7%
20.82
US$104,120 		5,000 -16.7% 20.82 US$104,120
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
25,000 -52.4%
20.51
US$512,692 		25,000 -52.4% 20.51 US$512,692
2019-02-08 2019-02-06 S Sale
Robbins Andrew R

COO
239,626 -80.0%
20.03
US$4,798,511 		239,626 -80.0% 20.03 US$4,798,511
2019-02-07 2019-02-05 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
40,000 -72.7%
20.00
US$800,000 		40,000 -72.7% 20.00 US$800,000
2019-02-01 2019-01-31 PlS Planned sale
0.8
Squarer Ron

CEO
113,438 -32.2%
18.53
US$2,101,541 		113,438 -32.2% 18.53 US$2,101,541
2019-02-01 2019-01-30 PlS Planned sale
0.8
Squarer Ron

CEO
100,000 -29.5%
18.25
US$1,825,370 		100,000 -29.5% 18.25 US$1,825,370
2019-01-29 2019-01-25 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
14,029 -78.2%
18.00
US$252,523 		14,029 -78.2% 18.00 US$252,523
2019-01-23 2019-01-18 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
1,251 -24.2%
18.00
US$22,518 		1,251 -24.2% 18.00 US$22,518
2019-01-17 2019-01-15 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
19,720 -83.4%
18.06
US$356,139 		19,720 -83.4% 18.06 US$356,139
2019-01-02 2018-12-27 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
6,268 -2.7%
14.05
US$88,091 		6,268 -2.7% 14.05 US$88,091
2018-12-06 2018-12-03 PlS Planned sale Sandor Victor

Chief Medical Officer
115,185 -34.1%
16.21
US$1,867,045 		115,185 -34.1% 16.21 US$1,867,045
2018-11-05 2018-11-01 B Purchase COX CARRIE SMITH
3,000 +inf%
16.87
US$50,595 		3,000 +inf% 16.87 US$50,595
2018-09-21 2018-09-19 PlS Planned sale VAN LUNSEN GIL J
18,000 -48.3%
14.76
US$265,684 		18,000 -48.3% 14.76 US$265,684
2018-09-05 2018-09-04 PlS Planned sale Sandor Victor

Chief Medical Officer
9,687 -4.4%
15.38
US$148,938 		9,687 -4.4% 15.38 US$148,938
2018-08-17 2018-08-15 PlS Planned sale Haddock Jason

CFO
20,000 -36.1%
13.92
US$278,400 		20,000 -36.1% 13.92 US$278,400
2018-08-17 2018-08-15 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
13.92
US$299,280 		21,500 -52.7% 13.92 US$299,280
2018-07-31 2018-07-30 PlS Planned sale Haddock Jason

CFO
25,000 -31.1%
14.87
US$371,750 		25,000 -31.1% 14.87 US$371,750
2018-07-19 2018-07-18 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
16.56
US$356,040 		21,500 -52.7% 16.56 US$356,040
2018-07-06 2018-07-06 S Sale LEFKOFF KYLE Non-Executive Director
50,000 -73.8%
17.45
US$872,500 		50,000 -73.8% 17.45 US$872,500
2018-06-29 2018-06-27 PlS Planned sale Robbins Andrew R

COO
17,964 -10.1%
17.74
US$318,681 		17,964 -10.1% 17.74 US$318,681
2018-06-29 2018-06-27 PlS Planned sale Squarer Ron

CEO
140,625 -39.9%
18.03
US$2,535,469 		140,625 -39.9% 18.03 US$2,535,469
2018-06-29 2018-06-27 PlS Planned sale Squarer Ron

CEO
43,628 -17.1%
17.74
US$773,961 		43,628 -17.1% 17.74 US$773,961
2018-06-21 2018-06-20 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
19.08
US$410,220 		21,500 -52.7% 19.08 US$410,220
2018-06-21 2018-06-19 PlS Planned sale Sandor Victor

Chief Medical Officer
77,576 -27.0%
18.76
US$1,455,326 		77,576 -27.0% 18.76 US$1,455,326
2018-06-15 2018-06-13 PlS Planned sale Sandor Victor

Chief Medical Officer
22,424 -9.6%
18.75
US$420,450 		22,424 -9.6% 18.75 US$420,450
2018-05-17 2018-05-16 PlS Planned sale VAN LUNSEN GIL J Non-Executive Director
21,500 -52.7%
15.36
US$330,259 		21,500 -52.7% 15.36 US$330,259
2018-04-18 2018-04-18 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
15.19
US$326,585 		21,500 -52.7% 15.19 US$326,585
2018-04-03 2018-04-03 PlS Planned sale Sandor Victor

Chief Medical Officer
8,689 -4.0%
15.35
US$133,376 		8,689 -4.0% 15.35 US$133,376
2018-03-21 2018-03-21 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
16.76
US$360,340 		21,500 -52.7% 16.76 US$360,340
2018-03-09 2018-03-09 PlS Planned sale Sandor Victor

Chief Medical Officer
111,518 -33.9%
17.72
US$1,976,099 		111,518 -33.9% 17.72 US$1,976,099
2018-03-09 2018-03-09 PlS Planned sale Sandor Victor

Chief Medical Officer
44,498 -11.9%
17.70
US$787,615 		44,498 -11.9% 17.70 US$787,615
2018-02-23 2018-02-21 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
17.16
US$368,940 		21,500 -52.7% 17.16 US$368,940
2018-02-12 2018-02-09 S Sale BAUM CHARLES M
50,000 -83.3%
16.90
US$845,000 		50,000 -83.3% 16.90 US$845,000
2018-02-12 2018-02-09 S Sale LEFKOFF KYLE
50,000 -73.8%
17.01
US$850,500 		50,000 -73.8% 17.01 US$850,500
2018-01-17 2018-01-17 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
12.94
US$278,210 		21,500 -52.7% 12.94 US$278,210
2018-01-16 2018-01-16 PlS Planned sale Haddock Jason

CFO
7,500 -20.6%
13.73
US$102,975 		7,500 -20.6% 13.73 US$102,975
2017-12-19 2017-12-19 PlS Planned sale Squarer Ron

CEO
546,233 -72.3%
10.93
US$5,970,327 		546,233 -72.3% 10.93 US$5,970,327
2017-12-19 2017-12-18 PlS Planned sale Squarer Ron

CEO
273,438 -56.6%
10.73
US$2,933,990 		273,438 -56.6% 10.73 US$2,933,990
2017-12-19 2017-12-18 PlS Planned sale Robbins Andrew R

COO
282,874 -64.1%
10.72
US$3,032,409 		282,874 -64.1% 10.72 US$3,032,409
2017-09-29 2017-09-29 S Sale LEFKOFF KYLE
38,865 -75.3%
12.31
US$478,428 		38,865 -75.3% 12.31 US$478,428
2017-09-29 2017-09-29 S Sale VAN LUNSEN GIL J
39,928 -72.3%
12.36
US$493,510 		39,928 -72.3% 12.36 US$493,510
2017-04-04 2017-03-31 S Sale LEFKOFF KYLE
45,000 -87.2%
8.92
US$401,400 		45,000 -87.2% 8.92 US$401,400
2017-03-30 2017-03-28 S Sale BAUM CHARLES M
25,000 -83.3%
9.27
US$231,750 		25,000 -83.3% 9.27 US$231,750
2016-09-30 2016-09-28 S Sale Redmile Group, LLC Large shareholder
2,492,578 -13.0%
6.36
US$15,852,796 		2,492,578 -13.0% 6.36 US$15,852,796
2016-09-16 2016-09-15 B Purchase Redmile Group, LLC Large shareholder
28,000 +0.1%
3.50
US$98,000 		28,000 +0.1% 3.50 US$98,000
2016-09-16 2016-09-15 S Sale Redmile Group, LLC Large shareholder
7,300 -0.0%
3.54
US$25,842 		7,300 -0.0% 3.54 US$25,842
2016-09-16 2016-09-14 B Purchase Redmile Group, LLC Large shareholder
372,000 +2.0%
3.51
US$1,305,720 		372,000 +2.0% 3.51 US$1,305,720
2016-09-16 2016-09-14 S Sale Redmile Group, LLC Large shareholder
392,700 -2.1%
3.50
US$1,374,450 		392,700 -2.1% 3.50 US$1,374,450
2016-01-22 2016-01-20 B Purchase Redmile Group, LLC Large shareholder
300,000 +1.6%
3.19
US$957,000 		300,000 +1.6% 3.19 US$957,000
2016-01-14 2016-01-12 B Purchase Redmile Group, LLC Large shareholder
75,000 +0.4%
3.60
US$270,000 		75,000 +0.4% 3.60 US$270,000
2016-01-11 2016-01-11 B Purchase Redmile Group, LLC Large shareholder
275,000 +1.5%
3.54
US$973,500 		275,000 +1.5% 3.54 US$973,500
2016-01-11 2016-01-08 B Purchase Redmile Group, LLC Large shareholder
350,000 +1.9%
3.72
US$1,302,000 		350,000 +1.9% 3.72 US$1,302,000
2016-01-11 2016-01-07 B Purchase Redmile Group, LLC Large shareholder
300,000 +1.7%
3.73
US$1,119,000 		300,000 +1.7% 3.73 US$1,119,000
2015-10-01 2015-10-01 B Purchase Redmile Group, LLC Large shareholder
100,140 +0.6%
4.50
US$450,630 		100,140 +0.6% 4.50 US$450,630
2015-10-01 2015-09-30 B Purchase Redmile Group, LLC Large shareholder
182,452 +1.0%
4.67
US$852,051 		182,452 +1.0% 4.67 US$852,051
2015-10-01 2015-09-29 B Purchase Redmile Group, LLC Large shareholder
500,000 +2.9%
4.56
US$2,280,000 		500,000 +2.9% 4.56 US$2,280,000
2015-08-28 2015-08-26 B Purchase Redmile Group, LLC Large shareholder
49,900 +0.3%
5.48
US$273,452 		49,900 +0.3% 5.48 US$273,452
2015-08-25 2015-08-25 B Purchase Redmile Group, LLC Large shareholder
220,000 +1.3%
5.45
US$1,199,000 		220,000 +1.3% 5.45 US$1,199,000
2015-08-25 2015-08-24 B Purchase Redmile Group, LLC Large shareholder
410,000 +2.5%
5.32
US$2,181,200 		410,000 +2.5% 5.32 US$2,181,200
2015-08-25 2015-08-21 B Purchase Redmile Group, LLC Large shareholder
160,000 +1.0%
5.45
US$872,000 		160,000 +1.0% 5.45 US$872,000
2015-08-13 2015-08-12 B Purchase Redmile Group, LLC Large shareholder
205,000 +1.3%
5.93
US$1,215,650 		205,000 +1.3% 5.93 US$1,215,650
2015-08-13 2015-08-11 B Purchase Redmile Group, LLC Large shareholder
327,500 +2.1%
5.85
US$1,915,875 		327,500 +2.1% 5.85 US$1,915,875
2015-08-10 2015-08-10 B Purchase Redmile Group, LLC Large shareholder
180,000 +1.1%
5.81
US$1,045,800 		180,000 +1.1% 5.81 US$1,045,800
Explore more

More insider trading research around Array BioPharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America